In summary, this study reports that oncogenic miR-500a-3p promotes the CSCs properties and tumourigenicity by negatively regulating SOCS2, SOCS4 and PTPN11, leading to activation of the STAT3 signalling pathway in hepatocellular carcinoma. The gene discussed is SOCS2; the disease is hepatocellular carcinoma.